Articles by Scott Fishman
-
4 Shortcomings Of Intellectual Property-Focused Investing
3/18/2016
Intellectual property (IP) is pretty foundational to qualifying many health care ventures as “investable.” In theory, this sounds like a good idea. But the unpredictability of patent enforcement, the expense of securing IP, and the X-factor of competition are among the reasons why IP isn't the "whole story" when it comes to launching a new product.
-
3 Mistakes To Avoid When Forecasting The Market For Your Medical Device
9/21/2015
I both conduct and teach due diligence, and I see a lot of business plans from healthcare entrepreneurs. Among other things, I look for a cogent value proposition, an understanding of an unmet need, and a realistic calculation of the addressable market.
-
Rethinking The Medtech Value Curve — Moving Beyond Feature- And Cost-Based Differentiation
6/17/2015
All product development ventures face the essential question of whether the opportunity is worth pursuing. Sometime in the distant past, before the hijacking of healthcare by the insurance industry — perhaps 15 or 20 years ago — the path from technology concept to medical device was a straightforward one. If you had an idea with clinical merit, and you were self-possessed and persistent enough, you probably could find a way to get your product to market.